Citadel Advisors - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 100 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$38,159,712
-52.1%
1,003,147
+14.7%
0.01%
-43.8%
Q2 2023$79,691,729
+108.5%
874,772
+51.0%
0.02%
+77.8%
Q1 2023$38,221,182
+50.8%
579,460
+18.2%
0.01%
+80.0%
Q4 2022$25,346,639
+7.1%
490,169
+41.4%
0.01%0.0%
Q3 2022$23,677,000
+18.0%
346,661
-21.9%
0.01%0.0%
Q2 2022$20,067,000
-44.7%
443,759
-37.9%
0.01%
-37.5%
Q1 2022$36,286,000
-38.7%
714,152
-43.0%
0.01%
-33.3%
Q4 2021$59,215,000
-35.3%
1,252,431
-54.9%
0.01%
-36.8%
Q3 2021$91,511,000
+168.3%
2,776,432
+414.4%
0.02%
+171.4%
Q2 2021$34,110,000
+446.1%
539,716
+270.8%
0.01%
+250.0%
Q1 2021$6,246,000
-92.7%
145,552
-90.3%
0.00%
-90.9%
Q4 2020$85,471,000
+26.6%
1,494,246
-33.2%
0.02%
+15.8%
Q3 2020$67,486,000
+43.6%
2,236,858
+55.5%
0.02%
+11.8%
Q2 2020$46,981,000
+101.4%
1,438,460
+65.2%
0.02%
+70.0%
Q1 2020$23,331,000
+19.9%
870,840
+37.0%
0.01%
+25.0%
Q4 2019$19,461,000
+19.7%
635,560
-1.0%
0.01%
+14.3%
Q2 2019$16,261,000
-11.8%
641,720
-32.1%
0.01%
-22.2%
Q1 2019$18,431,000
+2679.9%
945,184
+1780.3%
0.01%
Q4 2018$663,000
-41.4%
50,269
-21.1%
0.00%
-100.0%
Q3 2018$1,132,000
+358.3%
63,712
+465.5%
0.00%
Q2 2018$247,00011,2670.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders